Prostaglandins in primate semen: Biasing the immune system to benefit spermatozoa and virus?

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 57, Issue 2, 1997, Pages 113-118

  Kelly, R W ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYCLIC AMP; INTERLEUKIN 10; INTERLEUKIN 12; PROSTAGLANDIN DERIVATIVE;

ANIMAL TISSUE; ANTIGEN PRESENTING CELL; CONTROLLED STUDY; DRUG IDENTIFICATION; HELPER CELL; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE SYSTEM; IMMUNITY; LYMPHOCYTE PROLIFERATION; MALE; NATURAL KILLER CELL; NONHUMAN; PRIMATE; PRIORITY JOURNAL; REVIEW; SPERM; SPERMATOZOON; T LYMPHOCYTE; WART VIRUS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMA VIRUS; HUMAN PAPILLOMAVIRUS TYPES; PRIMATES;

EID: 0030832283     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-3278(97)90000-4     Document Type: Review

References (71)

1. James K., Hargreave T.B. Immunosuppression by seminal plasma and its possible clinical significance. Immunology Today 1984; 5: 357-363.
2. Alexander N.J., Anderson D.J. Immunology of Semen. Fertil Steri 1987; 47: 192-205.
3. Kelly R.W. Immunosuppressive mechanisms in semen: implications for contraception. Human Reproduction 1995; 10: 1686-1693.
4. Goldblatt M.W. A depressor substance in seminal fluid. J Soc Chem Indust 1933; 52: 1056-1061.
5. Von Euler U.S. On the specific vaso-dilating and plain muscle stimulating substances from accessory genital glands in man and certain animals (prostaglandin and vesiglandin). J Physiol (Lond) 1936; 88: 213-234.
6. Taylor P.L., Kelly R.W. 19-hydroxylated E prostaglandins as the major prostaglandins of human semen. Nature 1974; 250: 665-667.
7. Jonsson H.T., Middleditch B.S., Desiderio D.M. Prostaglandin in human seminal fluid: two novel compounds. Science 1975; 187: 1093-1094.
8. Kelly R.W., Taylor P.L., Hearn J.P., Short R.V., Martin D.E., Marston J.H. 19-Hydroxy prostaglandin E1 as a major component of the semen of primates. Nature 1976; 260: 544-555.
9. Poyser N.L. Some aspects of prostaglandins and reproduction. Biochem Soc Trans 1974; 2: 1196-2000.
10. Goodwin J.S., Bankhurst A.D., Messner R.P. Suppression of human T cell mitogenesis by prostaglandin. J Eptl Med 1977; 146: 1719-1734.
11. Chouaib S., Fradelizi D. The mechanism of inhibition of human IL-2 production. J Immunol 1982; 129: 2463-2468.
12. Rappaport R.S., Dodge G.R. Prostaglandin E inhibits the production of inlerleukin-2. J Exp Med 1982; 155: 943-948.
13. Droller M.J., Schneider M.U., Perlmann P. A possible role of prostaglandins in the inhibition of natural and antibody dependent lymphocyte cytotoxicity against tumor cells. Cell Immunol 1978; 39: 165-177.
14. Brunda M.J., Herberman R.B., Holden H.T. Inhibition of natural killer cell activity by prostaglandins. J Immunol 1980; 124: 2682-2687.
15. Bankhurst A.D. The modulation of human natural killer cell activity by prostaglandins. J Clin Lab Immunol 1982; 7: 85-91.
16. Stites D.P., Erickson R.P. Suppressive effect of seminal plasma on lymphocyte activation. Nature 1975; 253: 727-729.
17. Prakash C., Coutinho A., Moller G. Inhibition of in vitro immune responses by a fraction from seminal plasma. ScandJ Immunol 1976; 5: 77-88.
18. Lord E.M., Sensabaugh G.F., Stites D.P. Immunosuppressive activity of human seminal plasma 1, Inhibition of in vitro lymphocyte activation. J Immunol 1977; 118: 1704-1711.
19. James K., Szymaniec S. Human seminal plasma is a potent inhibitor of natural killer cell activity in vitro. J Reprod Immunol 1985; 8: 61-70.
20. Rees R.C., Vallely P.J., Clegg A., Potter C.W. Suppression of natural and activated antitumor cytotoxicity by human seminal plasma. Clin Exptl Immunol 1986; 63: 687-695.
21. Kelly R.W., Holland P., Skibinski G., Harrison C., McMillan L., Hargreave T.B., James K. Extracellular organelles (prostasomes) are immunosuppressive components of human semen. Clin Exptllmmunol 1991; 86: 550-556.
22. Quan C.P., Roux C., Pillot J., Bouvet J.-P. Delineation between T and B suppressive molecules from human seminal plasma: II Spermine is the major suppressor of T lymphocytes in vitro. Am J Reprod Immunol 1990; 22: 62-69.
23. Nocera M., Chu T.M. Transforming growth factor β as an immunosuppressive protein in human seminal plasma. Am J Reprod Immunol 1993; 30: 1-8.
24. Tarter T.H., Cunningham-Rundles S., Koide S.S. Suppression of natural killer cell activity by human seminal plasma in vitro: identification of 19-OH-PGE as the suppressor factor. J Immunol 1986; 136: 2862-2867.
25. Quayle A.J., Kelly R.W., Hargreave T.B., James K. Immunosuppression by seminal prostaglandins. Clin Exptl Immunol 1989; 75: 387-391.
26. Vallely P.J., Sharrard R.M., Rees R.C. The identification of factors in seminal plasma responsible for suppression of natural killer cell activity. Immunology 1988; 63: 451-456.
27. Kelly R.W., Carr G.C., Critchley H.O.D. A cytokine switch induced by human seminal plasma: an immune modulation with implications for sexually transmitted disease. Human Reprod 1997; 12: 677-681.
28. Kraan T.C.T.M.V., Boeije L.C.M., Smeenk R.J.T, Wijdenes J., Aarden L.A. Prostaglandin-E2 is a potent inhibitor of human interleukin-12 production. J Exp Med 1995; 181: 775-779.
29. Bogdan C., Paik J., Vodovotz Y., Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by TGFβ and IL-10. J Biol Chem 1992; 267: 23301-23308.
30. Strassmann G., Patil Koota V., Finkelman F., Fong M., Kambayashi T. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J Exp Med 1994; 180: 2365-2370.
31. Kleinnulend J., Semeins C.M., Burger E.H. Prostaglandin-mediated modulation of transforming growth-factor-beta metabolism in primary mouse osteoblastic cells in-vitro. J Cell Physiology 1996; 168: 1-7.
32. Mertz P.M., DeWitt D.L., Stetler Stevenson W.G., Wahl L.M. Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production. J Biol Chem 1994; 269: 21322-21329.
33. Brown C.Y., Lagnado C.A., Vadas M.A., Goodall G.J. Differential regulation of the stability of cytokine mRNAs in lipopolysaccharide-activated blood monocytes in response to interleukin-10. J Biol Chem 1996; 271: 20108-20112.
34. TagaK.,Tosato G. IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 1992; 148: 1143-1148.
35. Barrera S., Lai J., Fiocchi C., Roche J.K. Regulation by prostaglandin E(2) of interleukin release by T- lymphocytes in mucosa. J Cell Physiol 1996; 166: 130-137.
36. Krause D.S., Deutsch C. Cyclic AMP directly inhibits IL-2 receptor expression in human T cells: expression of both p55 and p75 subunits are affected. J Immunol 1991; 146: 2285-2294.
37. MosmannT.R., Coffman R.L. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol 1989; 46: 111-147.
38. Betz M., Fox B.S. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J Immunol 1991; 146: 108-113.
39. Naito Y., Endo H., Arai K.I., Coffman R.L., Arai N. Signal-transduction in Th clones - target of differential modulation by PGE(2) may reside downstream of the PKC-dependent pathway. Cytokine 1996; 8: 346-356.
40. Hilkens C.M.U., Snijders A., Vermeulen H., Vandermeide P.H., Wierenga E.A., Kapsenberg M.L. Accessory cell-derived IL-12 and prostaglandin E(2) determine the Ifn-gamma level of activated human Cd4(+) T-cells. J Immunol 1996; 156: 1722-1727.
41. Szabo S.J., Jacobson N.C., Dighe A.S., Gubler U., Murphy K.M. Developmental commitment to the Th2 lineage by extinction of IL-12 signalling. Immunity 1995; 2: 665-675.
42. Kaplan M.H., Sun Y.-L., Hoey T., Grusby M.J. Impaired IL-12 responses and enhanced development of Th2 cells in Stat-4-deficient mice. Nature 1996; 382: 174-177.
43. Trinchieri G., Gerosa F. Immunoregulation by interleukin-12. J Leuk Biol 1996; 59: 505-511.
44. Hall S.S. IL-12 at the crossroads. Science 1995; 268: 1432-1434.
45. Trinchieri G. IL-12 and its role in the generation of Th1 cells. Immunol Today 1993; 14: 335-338.
46. Macatonia S.E., Hosken N.A., Litton M., et al. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4(+) T-cells. J Immunol 1995; 154: 5071-5079.
47. Kang K.F., Kubin M., Cooper K.D., Lessin S.R., Trinchieri G., Rook A.H. Il-12 synthesis by human Langerhans cells. J Immunol 1996; 156: 1402-1407.
48. Cassatella M.A. The production of cytokines by polymorphonuclear neutrophils. Immunol Today 1995; 16: 21-26.
49. Ibelgaufts H., Dictionary of Cytokines. Weinheim: VCH,. 1995.
50. Chehimi J., Starr S.E., Frank I., et al. Natural Killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus infected patients. J Exp Med 1992; 175: 789-796.
51. D'Andrea A., Aste-Amezaga M., Valiante N.M., Ma X., Kubin M., Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte Interferon γ-production by suppressing natural killer stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993; 178: 1041-1048.
52. Muller G., Saloga J., Germann T., Schuler G., Knop J., Enk A.H. Il-12 As mediator and adjuvant for the induction of contact sensitivity in-vivo. J Immunol 1995; 155: 4661-4668.
53. Groux H., Bigler M., de Vries J.E., Roncarolo M.G. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med 1996; 184: 19-29.
54. Suzuki T., Tahara H., Narula S., Moore K.W., Robbins P.D., Lotze M.T. Viral interleukin-10 (IL-10), the human herpesvirus-4 cellular IL-10 homolog, induces local anergy to allogeneic and syngeneic tumors. J Exp Med 1995; 182: 477-486.
55. Bancroft G.J. The role of natural killer cells in innate resistance to infection. Curr Opinion Immunol 1993; 5: 503-510.
56. Martinvilla J.M., Luque I., Martinezquiles N., Corell A., Regueiro J.R., Timon M., Arnaizvillena A. Diploid expression of human-leukocyte antigen class-I and class-II molecules on spermatozoa and their cyclic inverse correlation with inhibin concentration. Biol Reprod 1996; 55: 620-629.
57. Vince G.S., Johnson P.M. Materno-fetal immunobiology in normal pregnancy and its possible failure in recurrent spontaneous abortion? Human Reprod 1995; 10 supplement 2: 107-113.
58. Matzinger P. Tolerance, danger, and the extended family. Ann Rev Immunol 1994; 12: 991-1045.
59. Medzhitov R., Janeway C.A. Innate immunity: impact on the adaptive immune repsonse. Curr Opinion Immunol 1997; 9: 4-9.
60. Mannie M.D., Prevost K.D., Marinakis C.A. Prostaglandin E(2) promotes the induction of anergy during T-helper cell recognition of myelin basic-protein. Cell Immunol 1995; 160: 132-138.
61. Robillard P.Y., Hulsey T.C., Périanin J., Janky E., Miri E.H., Papiernik E. Association of pregnancy induced hypertension with duration of sexual cohabitation before conception. Lancet 1994; 344: 973-975.
62. Pollak R., Dumble L.J., Wiederkehr J.C., Maddux M.S. The immunosuppressive properties of new oral prostaglandin E1 analogs. Transplantation 1990; 50: 834-838.
63. Viera P., deWaal-Malefyt R., Dang M.N., et al. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRF1. Proc Nat Acad Sci, USA 1991; 88: 1172-1176.
64. Karp C.L., Wysocka M., Wahl L.M., Ahearn J.M., Cuomo P.J., Sherry B., Trinchieri G., Griffin D.E. Mechanism of suppression of cell-mediated-immunity by measles-virus. Science 1996; 273: 228-231.
65. Nokta M.A., Hassan M.I., Loesch K., Pollard R.B. Human cytomegalovirus-induced immunosuppression - relationship to tumor necrosis factor-dependent release of arachidonic-acid and prostaglandin E(2) in human monocytes. J Clin Invest 1996; 97: 2635-2641.
66. Ibata B., Parr E.L., King N.J.C., Parr M.B. Migration of foreign lymphocytes from the mouse vagina into cervicovaginal mucosa and to the iliac lymph nodes. Biol Reprod 1997; 56: 537-543.
67. Walker C.M., Moody D.J., Stites D.P., Levy J.A. CD8+ lymphocytes can control HIV infection in vitro by suppresing virus replication. Science 1986; 234: 1563-1566.
68. Barker E., Mackewicz C.E., Levy J.A. Effects of T(h)1 and T(h)2 cytokines on CD8(+) cell response against human-immunodeficiency-virus - implications for long-term survival. Proc Nat Acad Sci USA 1995; 92: 11135-11139.
69. Spira A.I., Marx P.A., Patterson B.K., Mahoney J., Koup R.A., Wolinsky S.M., Ho D.D. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J Exp Med 1996; 183: 215-225.
70. Ghanekar S., Zheng L., Logar A., Navratil J., Borowski L.A., Gupta P., Rinaldo C. Cytokine expression by human peripheral-blood dendritic cells stimulated in-vitro with HIV-1 and herpes-simplex virus. J Immunol 1996; 157: 4028-4036.
71. Guidotti L.G., Chisari F.V. To kill or to cure: options of host defense against viral infection. Curr Opinion Immunol 1996; 8: 478-483.